Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Hyperlipidemia, Dyslipidemia”

289 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 289 results

Early research (Phase 1)Study completedNCT01435382
What this trial is testing

A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia

Who this might be right for
HypercholesterolemiaDyslipidemiasHyperlipidemias+2 more
Pfizer 49
Large-scale testing (Phase 3)Study completedNCT01514461
What this trial is testing

A Randomized, Double-blind, Placebo Controlled Study to Assess Efficacy, Safety and Tolerability of LCQ908 in Subjects With Familial Chylomicronemia Syndrome

Who this might be right for
Familial Chylomicronemia Syndrome (FCS)
Novartis Pharmaceuticals 45
Testing effectiveness (Phase 2)Study completedNCT00562575
What this trial is testing

Evaluation of Safety and Effects of SLx-4090 After Dosing for 14 Days in Subjects With High Triglycerides

Who this might be right for
Hypertriglyceridemia
Response Pharmaceuticals 24
Post-approval studies (Phase 4)Study completedNCT00407537
What this trial is testing

Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors

Who this might be right for
HypertensionHypercholesterolemia
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 1,531
Testing effectiveness (Phase 2)Ended earlyNCT05217667
What this trial is testing

Study of ARO-ANG3 in Participants With Homozygous Familial Hypercholesterolemia (HOFH)

Who this might be right for
Homozygous Familial Hypercholesterolemia
Arrowhead Pharmaceuticals 18
Not applicableStudy completedNCT02770131
What this trial is testing

Chart Review of Repatha® in Subjects With Hyperlipidaemia

Who this might be right for
Hypercholesterolaemia
Amgen 1,986
Post-approval studies (Phase 4)Ended earlyNCT00651378
What this trial is testing

Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)

Who this might be right for
HypercholesterolemiaAtherosclerosisCoronary Artery Disease
Organon and Co 87
Early research (Phase 1)Study completedNCT04058834
What this trial is testing

A Research Study Investigating How NNC0385-0434 is Tolerated in People With or Without High Cholesterol Levels

Who this might be right for
Healthy VolunteersHypercholesterolaemia
Novo Nordisk A/S 39
Large-scale testing (Phase 3)Study completedNCT00812955
What this trial is testing

Safety and Efficacy Study Comparing ABT-143 to Simvastatin in Subjects With Elevated Levels of Low Density Lipoprotein Cholesterol ("Bad Cholesterol") and Triglycerides

Who this might be right for
Dyslipidemia, Hypercholesterolemia, Hypertriglyceridemia
AstraZeneca 474
Testing effectiveness (Phase 2)Study completedNCT04573218
What this trial is testing

Supplementation of Oil Palm Phenolics to Improve Lipid Profile in Subjects With Minor Hyperlipidaemia

Who this might be right for
HyperlipidemiasHypercholesterolemia
Isa Naina Mohamed 50
Large-scale testing (Phase 3)Study completedNCT00134485
What this trial is testing

Study To Evaluate The Safety And Efficacy Of Torcetrapib/Atorvastatin In Subjects With Familial Hypercholerolemia

Who this might be right for
Hypercholesterolemia, FamilialHyperlipidemia
Pfizer 400
Post-approval studies (Phase 4)Study completedNCT00653835
What this trial is testing

Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)

Who this might be right for
HypercholesterolaemiaAtherosclerosis
Organon and Co 153
Large-scale testing (Phase 3)Study completedNCT00650689
What this trial is testing

Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)

Who this might be right for
HypercholesterolemiaAtherosclerosisCoronary Artery Disease
Organon and Co 122
Large-scale testing (Phase 3)Study completedNCT03882892
What this trial is testing

Long-Term Safety and Tolerability of Ezetimibe (SCH 58235, MK-0653) With Atovastatin (P02154, MK-0653-017)

Who this might be right for
Hypercholesterolemia
Organon and Co 400
Large-scale testing (Phase 3)Study completedNCT00654394
What this trial is testing

Progression of Carotid Artery Atheroma in Moderately Hypercholesterolemic Subjects

Who this might be right for
Carotid Artery StenosisHypercholesterolemia
AstraZeneca 200
Testing effectiveness (Phase 2)Study completedNCT03216811
What this trial is testing

Nutraceutical in Cardiovascular Primary Prevention

Who this might be right for
Hypercholesterolemia
University Hospital of Ferrara 52
Large-scale testing (Phase 3)Study completedNCT00249912
What this trial is testing

Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia

Who this might be right for
Hypercholesterolemia
Takeda 415
Large-scale testing (Phase 3)Study completedNCT00214604
What this trial is testing

Type III Dysbetalipoproteinemia

Who this might be right for
Hyperlipoproteinemia Type III
AstraZeneca 30
Not applicableUnknownNCT06368258
What this trial is testing

Middle Term Effect of Red Yeast Rice on Plasma Lipids and Proteoma in Individuals With Suboptimal Cholesterolemia

Who this might be right for
Hypercholesterolemia
University of Bologna 40
Early research (Phase 1)Ended earlyNCT01082562
What this trial is testing

Safety Study of BMS-844421 for Treatment of Hypercholesterolemia

Who this might be right for
AtherosclerosisHypercholesterolemia
Bristol-Myers Squibb 40
Next Page